相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
miR-124 Inhibits STAT3 Signaling to Enhance T Cell-Mediated Immune Clearance of Glioma
Jun Wei et al.
CANCER RESEARCH (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
Mouldy Sioud et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Superior T memory stem cell persistence supports long-lived T cell memory
Enrico Lugli et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
Chan-Juan Shen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
Linda Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas
Kentaro Mitsuka et al.
NEUROSURGERY (2013)
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Lisa Christiansson et al.
PLOS ONE (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia
Junko Baba et al.
BLOOD (2012)
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy
Sivan Sapoznik et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
Christiane Sahm et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
Richard C. Koya et al.
CANCER RESEARCH (2012)
Regulatory T Cells Move in When Gliomas Say I DO
Bryan D. Choi et al.
CLINICAL CANCER RESEARCH (2012)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2012)
Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme
Tania Crough et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma
Krithika N. Kodumudi et al.
JOURNAL OF IMMUNOLOGY (2012)
Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy?
Christopher A. Klebanoff et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
Alexia Ghazi et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Sequential Immunotherapy by Vaccination With GM-CSF-expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
Pankaj Agarwalla et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Immunotherapy for Glioma Promises and Challenges
Seunggu J. Han et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer
Shinji Ohki et al.
ONCOLOGY REPORTS (2012)
A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
John H. Sampson et al.
PLOS ONE (2012)
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
Taku Fujimura et al.
ONCOIMMUNOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
Rikke Baek Sorensen et al.
BLOOD (2011)
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
Duane A. Mitchell et al.
BLOOD (2011)
In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
De-Gang Song et al.
CANCER RESEARCH (2011)
Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
Romain Bedel et al.
CANCER RESEARCH (2011)
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong et al.
CANCER RESEARCH (2011)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype
Kristine Dziurzynski et al.
CLINICAL CANCER RESEARCH (2011)
Costimulation by chimeric antigen receptors revisited: the T cell antitumor response benefits from combined CD28-OX40 signalling
Andreas A. Hombach et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Wei Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Activation of Wnt Signaling Arrests Effector Differentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes
Sujatha Muralidharan et al.
JOURNAL OF IMMUNOLOGY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme
Nichole L. Bryant et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
Xinmei Zhu et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The detection of CMV pp65 and IE1 in glioblastoma multiforme
Kenneth G. Lucas et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Vinod P. Balachandran et al.
NATURE MEDICINE (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
U. Bogdahn et al.
NEURO-ONCOLOGY (2011)
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri et al.
NEURO-ONCOLOGY (2011)
Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner
Hao Zhou et al.
AUTOIMMUNITY (2010)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Laetitia Aymeric et al.
CANCER RESEARCH (2010)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
Andrea Boni et al.
CANCER RESEARCH (2010)
Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
Tai-Gyu Kim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor beta-Insensitive CD8(+) T Cells
Longxin Wang et al.
CLINICAL CANCER RESEARCH (2010)
Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Darya Alizadeh et al.
CLINICAL CANCER RESEARCH (2010)
Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Jenny J. Hong et al.
CLINICAL CANCER RESEARCH (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2010)
T-cell immunotherapy for malignant glioma: toward a combined approach
Pierre-Yves Dietrich et al.
CURRENT OPINION IN ONCOLOGY (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The role of microglia in central nervous system immunity and glioma immunology
Isaac Yang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD4+CD25+Foxp3+ Regulatory T Cells Optimize Diversity of the Conventional T Cell Repertoire during Reconstitution from Lymphopenia
Colleen J. Winstead et al.
JOURNAL OF IMMUNOLOGY (2010)
Depletion of Regulatory T Cells Facilitates Growth of Established Tumors: A Mechanism Involving the Regulation of Myeloid-Derived Suppressor Cells by Lipoxin A4
Biao Zhang et al.
JOURNAL OF IMMUNOLOGY (2010)
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John A. Craddock et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein
Anusha Kalbasi et al.
JOURNAL OF IMMUNOTHERAPY (2010)
TCR gene-engineered T cell: Limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity
Nadine Pouw et al.
MOLECULAR IMMUNOLOGY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
Jennifer C. Rodrigues et al.
NEURO-ONCOLOGY (2010)
The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention
William Humphries et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
David J. Chung et al.
BLOOD (2009)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Immunotherapy of cancer
Hossein Borghaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Treatment of malignant gliomas with TGF-β2 antisense oligonucleotides
Peter Hau et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
gamma delta T cells as immune effectors against high-grade gliomas
Lawrence S. Lamb
IMMUNOLOGIC RESEARCH (2009)
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1
Makoto Okada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Disruption of TGF-β Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity
Ulf Petrausch et al.
JOURNAL OF IMMUNOLOGY (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
Robert Owen Dillman et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Szofia S. Bullain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy Laboratory investigation
Takeshi Miyazaki et al.
JOURNAL OF NEUROSURGERY (2009)
Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7
Juan F. Vera et al.
MOLECULAR THERAPY (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
Florence R. Depontieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genetic modification of natural killer cells for adoptive cellular immunotherapy
Hollie J. Pegram et al.
IMMUNOTHERAPY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Christopher J. Wheeler et al.
CANCER RESEARCH (2008)
Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells
Peng Wang et al.
CELLULAR IMMUNOLOGY (2008)
Transforming growth factor-β receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers
Africa Wallace et al.
CLINICAL CANCER RESEARCH (2008)
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
Jill Wykosky et al.
CLINICAL CANCER RESEARCH (2008)
Natural killer cell immunotherapy for cancer: a new hope
S. Srivastava et al.
CYTOTHERAPY (2008)
Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL
W. Jiang et al.
CYTOTHERAPY (2008)
From oncogene to network addiction: the new frontier of cancer genomics and therapeutics
Giovanni Tonon
FUTURE ONCOLOGY (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Regulatory CD4(+)CD25(+)Foxp3(+) T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells
Colleen J. Winstead et al.
JOURNAL OF IMMUNOLOGY (2008)
Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma
Mitsugu Fujita et al.
JOURNAL OF IMMUNOLOGY (2008)
Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma
Nobusada Koike et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma
F. Stephen Hodi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Justin T. Jordan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
Hideho Okada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein
Hyun-Il Cho et al.
CANCER LETTERS (2007)
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Matthias T. Stephan et al.
NATURE MEDICINE (2007)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model (vol 9, pg 259, 2007)
Thomas-Toan Tran
NEURO-ONCOLOGY (2007)
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo
Daniel J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells
Stephen R. Goding et al.
HUMAN GENE THERAPY (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8+ T cells
Claudia Wrzesinski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
Jian Gang Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
Marc Schmitz et al.
CANCER LETTERS (2007)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
Xinglei Shen et al.
JOURNAL OF IMMUNOTHERAPY (2007)
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M. Kowolik et al.
CANCER RESEARCH (2006)
Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion
Daniel J. Powell et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
Marc Bonneville et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to Vα24+ NKT cell-mediated cytotoxicity
Stephen R. Mattarollo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Cytolytic and cytotoxic activity of a human natural killer cell line genetically modified to specifically recognize HER-2/neu overexpressing tumor cells
F. J. Demirtzoglou et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Autoimmunity during lymphopenia: A two-hit model
Tom Krupica et al.
CLINICAL IMMUNOLOGY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
CD4+-CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2006)
Surface NK receptors and their ligands on tumor cells
Lorenzo Moretta et al.
SEMINARS IN IMMUNOLOGY (2006)
Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas
AH Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Y Zhang et al.
NATURE MEDICINE (2005)
Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine
C Hsu et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
EphA2 as a glioma-associated antigen: A novel target for glioma vaccines
M Hatano et al.
NEOPLASIA (2005)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
G Dotti et al.
BLOOD (2005)
Adoptive transfer of tumor-reactive transforming growth factor-β-insensitive CD8+ T cells:: Eradication of autologous mouse prostate cancer
Q Zhang et al.
CANCER RESEARCH (2005)
Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor
T Schirrmann et al.
LEUKEMIA RESEARCH (2005)
Bcl-2 overexpression enhances tumor-specific T-cell survival
J Charo et al.
CANCER RESEARCH (2005)
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity
C King et al.
CELL (2004)
Identification of a human glioma antigen, SOX6, recognized by patients' sera
R Ueda et al.
ONCOGENE (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma
RO Dillman et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
KS Kahlon et al.
CANCER RESEARCH (2004)
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells
G Liu et al.
CANCER RESEARCH (2004)
Regulation and role of transforming growth factor-β in immune tolerance induction and inflammation
CB Schmidt-Weber et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model
E Ishikawa et al.
CANCER SCIENCE (2004)
AIM-2: A novel tumor antigen is expressed and presented by human glioma cells
GT Liu et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas
M Platten et al.
ANNALS OF NEUROLOGY (2003)
Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence
S Cavalieri et al.
BLOOD (2003)
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma
GT Liu et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Adoptive immunotherapy for malignant glioma
DA Mitchell et al.
CANCER JOURNAL (2003)
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2002)
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
MH Kershaw et al.
HUMAN GENE THERAPY (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection
M Friberg et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
T cell homeostatic proliferation elicits effective antitumor autoimmunity
W Dummer et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo
T Schirrmann et al.
CANCER GENE THERAPY (2002)
Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
W Asavaroengchai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity
K Liu et al.
JOURNAL OF IMMUNOLOGY (2001)
Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ lymphocyte immortalization
M Migliaccio et al.
JOURNAL OF IMMUNOLOGY (2000)
Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase
E Hooijberg et al.
JOURNAL OF IMMUNOLOGY (2000)
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells
BK Cho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma
GW Wood et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
P Hwu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
